FABIANI, IACOPO
 Distribuzione geografica
Continente #
NA - Nord America 2.653
AS - Asia 2.529
EU - Europa 2.150
SA - Sud America 596
AF - Africa 75
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.011
Nazione #
US - Stati Uniti d'America 2.498
SG - Singapore 1.029
IT - Italia 712
RU - Federazione Russa 674
CN - Cina 645
BR - Brasile 468
VN - Vietnam 348
HK - Hong Kong 146
GB - Regno Unito 126
DE - Germania 121
NL - Olanda 111
FR - Francia 105
FI - Finlandia 88
CA - Canada 84
TR - Turchia 62
IN - India 57
BD - Bangladesh 54
MX - Messico 50
PL - Polonia 44
IE - Irlanda 40
AR - Argentina 37
ZA - Sudafrica 31
EC - Ecuador 30
ID - Indonesia 29
IQ - Iraq 28
ES - Italia 25
PK - Pakistan 23
JP - Giappone 19
UA - Ucraina 19
SE - Svezia 18
CO - Colombia 17
AT - Austria 15
IL - Israele 14
SA - Arabia Saudita 14
VE - Venezuela 14
MA - Marocco 12
LT - Lituania 11
PE - Perù 9
PY - Paraguay 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
BE - Belgio 7
EG - Egitto 7
MY - Malesia 7
CL - Cile 6
DO - Repubblica Dominicana 6
JO - Giordania 6
AU - Australia 5
DZ - Algeria 5
GR - Grecia 5
KE - Kenya 5
KZ - Kazakistan 5
BO - Bolivia 4
CH - Svizzera 4
LB - Libano 4
PH - Filippine 4
RO - Romania 4
CR - Costa Rica 3
CZ - Repubblica Ceca 3
HU - Ungheria 3
JM - Giamaica 3
KR - Corea 3
MG - Madagascar 3
SI - Slovenia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AL - Albania 2
AO - Angola 2
AZ - Azerbaigian 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
KG - Kirghizistan 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PS - Palestinian Territory 2
TH - Thailandia 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CG - Congo 1
CU - Cuba 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GD - Grenada 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
LY - Libia 1
PA - Panama 1
PG - Papua Nuova Guinea 1
PT - Portogallo 1
QA - Qatar 1
SN - Senegal 1
Totale 8.007
Città #
Dallas 809
Singapore 594
Ashburn 299
San Jose 273
Beijing 235
Hong Kong 142
Moscow 135
Ho Chi Minh City 124
Los Angeles 94
Hanoi 66
Milan 65
New York 63
São Paulo 60
The Dalles 56
Council Bluffs 52
Munich 51
Helsinki 48
Santa Clara 47
Lauterbourg 45
Rome 44
Hefei 42
Dublin 40
Boardman 39
Warsaw 37
Istanbul 35
Pisa 34
Florence 32
London 32
Lappeenranta 28
Montreal 28
Denver 27
Mexico City 27
Orem 27
Naples 26
Buffalo 25
Amsterdam 24
Frankfurt am Main 24
Johannesburg 24
Beauharnois 23
Brooklyn 21
Chennai 21
Genoa 21
Houston 21
Rio de Janeiro 21
Chicago 20
Haiphong 20
Lucca 19
Nuremberg 19
Tokyo 18
Phoenix 17
Stockholm 17
Atlanta 16
Da Nang 16
Poplar 16
Toronto 14
Boston 13
Mumbai 13
Seattle 13
Curitiba 12
Manchester 12
Guayaquil 11
Paris 11
San Francisco 11
Ankara 10
Assago 10
Belo Horizonte 10
Biên Hòa 10
Quito 10
Bologna 9
Brasília 9
Brescia 9
Palermo 9
Tel Aviv 9
Turin 9
Turku 9
Washington 9
Cascina 8
Dhaka 8
Guangzhou 8
Hillsboro 8
Hải Dương 8
Porto Alegre 8
Salt Lake City 8
Shenzhen 8
Brussels 7
Charlotte 7
Goiânia 7
Lahore 7
Livorno 7
Phủ Lý 7
Vienna 7
Bari 6
Casablanca 6
Chengdu 6
City of London 6
Faisalabad 6
Kuala Lumpur 6
Redondo Beach 6
Santa Croce sull'Arno 6
Shanghai 6
Totale 4.558
Nome #
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 553
Trastuzumab cardiotoxicity and drug cardioprotection in healthy and cardiac dysfunction mouse models 366
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 269
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 256
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 252
Atrial amyloidosis: mechanisms and clinical manifestations 248
Role of Imaging in Cardiomyopathies 228
Approccio critico all’interpretazione dei trial cardiovascolari con risultati neutri o negativi 223
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology 219
Disease features and management of cardiomyopathies in women 219
Haemodynamic forces predicting remodelling and outcome in patients with heart failure treated with sacubitril/valsartan 218
Valvular heart disease in patients with cardiac amyloidosis 205
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis 204
Echocardiographic findings in subjects with an amyloidogenic apolipoprotein A1 pathogenic variant 203
Valve disease in cardiac amyloidosis: an echocardiographic score 195
Sex-specific associations of myocardial perfusion imaging with outcomes in patients with suspected chronic coronary syndrome 193
Assessing cardiac mechanics through left ventricular haemodynamic forces 193
Cardiovascular toxicity from therapies for light chain amyloidosis 193
Use of new and emerging cancer drugs: what the cardiologist needs to know 190
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 188
Clinical management of drug-induced cardiotoxicity in patients with HER-2+ breast cancer: current recommendations and future outlook 187
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 180
Etiological Treatment of Cardiac Amyloidosis: Standard of Care and Future Directions 178
Management and treatment of cardiotoxicity due to anticancer drugs: 10 questions and answers 177
Exercise limitations in amyloid cardiomyopathy assessed by cardiopulmonary exercise testing—A multicentre study 172
Treatment Options in AF Patients with Cancer; Focus on Catheter Ablation 169
Echocardiographic Estimate of Pulmonary Capillary Wedge Pressure Improves Outcome Prediction in Heart Failure Patients with Reduced and Mildly Reduced Ejection Fraction 161
Advancing Cardiovascular Risk Stratification and Functional Assessment: A Narrative Review of CPET and ESE Applications 157
The Mayo ATTR‐CM score versus other diagnostic scores and cardiac biomarkers in patients with suspected cardiac amyloidosis 156
Galectin-3 and Risk for Cancer or Heart Failure: Does Sex Matter? 153
Critical Reading of cardiovascular trials with neutral or negative results 150
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 148
Magnetic resonance imaging for diagnostic workup of embolic stroke of undetermined source: A systematic review 148
Partial Lipodystrophy and LMNA p.R545H Variant 147
Exercise oscillatory ventilation in heart failure and brain–lung–heart–muscle crosstalk 144
More cardiopulmonary effort testing needed in HFpEF! 136
Ischemic Heart Disease in Liver Transplant Candidates With High Bleeding Risk: Any Way Out? 131
Post-acute cardiac complications following SARS-CoV-2 infection in partial lipodystrophy due to LMNA gene p.R349W mutation 122
Non-pegylated liposomal doxorubicin in older adjuvant early breast cancer patients: cardiac safety analysis and final results of the COLTONE study 119
Response to ‘Is the left atrium the key in the amyloid imaging lock?’ 109
Safety and Effectiveness of Sodium-Glucose Co-Transporter 2 Inhibitors in Active Cancer Patients with Heart Failure: Results of the Observational TOSCA Trial 107
Serum and Tissue Light-Chains as Disease Biomarkers in AL Amyloidosis 51
null 29
PAWP vs LVEDP During Invasive Cardiopulmonary Exercise Testing: In Search of the Holy Grail of a Hemodynamic Truth in Heart Failure. 16
Totale 8.062
Categoria #
all - tutte 32.466
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.466


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202347 0 0 0 0 4 5 4 6 18 5 5 0
2023/2024246 1 0 48 34 10 22 30 8 6 16 14 57
2024/20252.115 40 48 85 51 121 122 291 414 200 149 276 318
2025/20265.654 379 726 859 941 619 466 559 313 447 345 0 0
Totale 8.062